Aufklappen
Schliessen
- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten |
|---|---|
| 11:13 | Lilly, Nektar to co-develop new immunotherapy |
| 10:12 | RCGP warns that GP access is set to worsen |
| 10:12 | MSD's Keytruda backed for bladder cancer |
| 10:12 | ViiV's long-acting two-drug HIV regimen hits targets |
| Mo | GSK files for extended use of Relvar Ellipta in asthma |
| Mo | NHS England consults on blocking 'wasteful' prescriptions |
| Mo | Merck, Pfizer's avelumab clears first hurdle in early access scheme |
| Mo | Eleven medicines leap closer to EU approval |
| Fr | NICE u-turn backs use of Teva's asthma biologic |
| Fr | EU nod for Vifor's Veltassa |
| Fr | Tentative US approval for Merck's diabetes therapy |
| Fr | Sanofi, Ablynx sign $2.7bn research, licensing pact |
| Fr | Do you love your team? |
| Fr | Future Thinking appoints new heads of pharma and healthcare |
| Do | EU approves LEO Pharma's psoriasis biologic |
| Do | Final NHS green light for Amgen's Kyprolis |
| Do | 'Compelling' mid-stage data for Vertex' CF drugs |
| Do | GSK to cut 320 jobs amid manufacturing revamp |
| Mi | EU nod for Gedeon's novel antipsychotic Reagila |
| Mi | US nod for Gilead's pan-genotypic hep C pill |
| Mi | Publicis Health UK announces senior promotions |
| Mi | Shire bags rights to bi-specific antibody for haemophilia |
| Mi | AXON finds new PR director |
| Mi | New host manager for QuintilesIMS UK & Ireland |
| 18.07. | Communications Team of the Year 2017: Why agencies love taking part (…and you would too!) |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von